KAT6A and leukemia: Collectively, by elucidating the interplay between chromatin dynamics, histone modifications, and transcriptional regulation in KAT6A-rearranged AML, this study provides a foundation for innovative therapeutic strategies targeting epigenetic vulnerabilities in this rare but aggressive leukemia subtype.